NAD Has ‘High Hopes’ Firms Will Cooperate On Schedules To Accelerate Reviews
This article was originally published in The Rose Sheet
Executive Summary
The National Advertising Division changes its review process to allow opposing companies greater control over scheduling and resolving their disputes. The changes, recommended by ABA committees, also impose fees on both firms in appeals and allow more time for compliance with decisions.
You may also be interested in...
NAD Fed Up With ‘Confidentiality’ Cop-Outs; Are Advertisers ‘Hiding The Ball’?
The National Advertising Division is weary of companies claiming confidentiality in its dispute resolution forum without adequately detailed cause or earnest efforts to meet the option’s requirements. A panel at the group’s annual meeting discussed the issue and steps advertisers should take to protect their competitive interests without compromising themselves or the self-regulatory system.
Flonase Ad Claims Settlement Confidential, But McNeil Likely Gains Choosing Court Over NAD
When prompt action is a primary goal, as McNeil aimed for in challenging ad claims for Glaxo’s Flonase Allergy Relief, lawyers say going to court is a better option than going to the National Advertising Division. Even with allegations that wither under the opposing firm’s rebuttal, litigation of advertising complaints it gains publicity than a NAD review would generate.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.